Novel deuterated JAK2 inhibitor, preparation method therefor and use thereof

WO2026138008A1PCT designated stage Publication Date: 2026-07-02HC SYNTHETIC PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
HC SYNTHETIC PHARMA CO LTD
Filing Date
2025-09-15
Publication Date
2026-07-02

Smart Images

  • Figure PCTCN2025121396-FTAPPB-I100001
    Figure PCTCN2025121396-FTAPPB-I100001
  • Figure PCTCN2025121396-FTAPPB-I100002
    Figure PCTCN2025121396-FTAPPB-I100002
  • Figure PCTCN2025121396-FTAPPB-I100003
    Figure PCTCN2025121396-FTAPPB-I100003
Patent Text Reader

Abstract

The present invention belongs to the technical field of biomedicine, and specifically relates to a novel deuterated JAK2 inhibitor or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art